Assessing Punctate Administration of Beta-alanine as a Potential Human Model of Non-histaminergic Itch by Christensen, Janne D et al.
 
  
 
Aalborg Universitet
Assessing Punctate Administration of Beta-alanine as a Potential Human Model of
Non-histaminergic Itch
Christensen, Janne D; Lo Vecchio, Silvia; Elberling, Jesper; Arendt-Nielsen, Lars; Andersen,
Hjalte H
Published in:
Acta Dermato-Venereologica
DOI (link to publication from Publisher):
10.2340/00015555-3067
Creative Commons License
CC BY-NC 4.0
Publication date:
2019
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Christensen, J. D., Lo Vecchio, S., Elberling, J., Arendt-Nielsen, L., & Andersen, H. H. (2019). Assessing
Punctate Administration of Beta-alanine as a Potential Human Model of Non-histaminergic Itch. Acta Dermato-
Venereologica, 99(2), 222-223. https://doi.org/10.2340/00015555-3067
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
A
ct
aD
V
A
ct
aD
V
A
d
v
a
n
c
e
s 
in
 d
e
rm
a
to
lo
g
y
 a
n
d
 v
e
n
e
re
o
lo
g
y
A
c
ta
 D
e
rm
a
to
-V
e
n
e
re
o
lo
g
ic
a
SHORT COMMUNICATION
doi: 10.2340/00015555-3067
Journal Compilation © 2019 Acta Dermato-Venereologica. 
This is an open access article under the CC BY-NC license. www.medicaljournals.se/acta
Acta Derm Venereol 2019; 99: 222–223
222
Itch is a frequent symptom in many dermatological, syste-
mic and neuropathic diseases (1). Several populations of 
thin primary afferents respond to a variety of pruritogens 
(2). In many diseases, such as atopic dermatitis (AD), 
itch is thought to be transmitted non-histaminergically 
(3). This fits the observation that antihistamines are inef-
fective in AD (4). For mechanistic studies, pharmaceu-
tical proof-of-concept studies, and in relation to sensory 
phenotyping of chronic itch patients, reliable provocation 
models of histamine-independent itch 
are important (5). The cowhage-model 
has become the “gold standard” of non-
histaminergic evoked itch in humans (6, 
7), and while it is a very effective model 
it suffers from several drawbacks: (i) 
carefully controlled applications of the 
spiculae are impossible, (ii) no com-
mercial outlet supplies the spiculae, 
(iii), and batch-to-batch and inter-strain 
differences appear to be present. With 
this in mind, we aimed to develop a new 
and easily standardizable itch model re-
lying on β-alanine, a naturally occurring 
amino acid. β-alanine evokes itch and 
a pricking sensation upon intradermal 
injection through activation of superfici-
ally terminating mas-related G-protein-
coupled receptor (Mrgpr) D-expressing 
neurones (8, 9). In non-human primates 
the primary afferent C-fibre population 
activated by β-alanine is distinct from 
that activated by histamine (10). The 
present study characterized the dose-
response features of the β-alaninergic 
model of itch introduced with skin prick 
test (SPT) lancets in human skin. For 
comparative purposes itch provocations 
with cowhage and histamine were con-
ducted and hyperknesis and cutaneous 
flare reactions were monitored. 
METHODS (see Appendix S11)
RESULTS 
β-alanine introduced with SPT lancets 
did not exhibit clear dose-response 
features (no differences between any of the β-alanine 
conditions) (Fig. 1A–C). This was true both for the 
mean and peak itch intensities and also independent of 
the numbers of SPT lancet punctures conducted, i.e. 1 
vs. 5 vs. 25 (Fig. 1D–F). Compared with both histamine 
and cowhage, β-alanine induced significantly less robust 
itch. The temporal profiles of itch were different between 
cowhage and histamine, with cowhage exhibiting a more 
rapidly occurring peak and a faster decline than histamine. 
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Fig. 1. (A) Temporal profile, (B) mean, and (C) peak itch intensities induced by different 
pruritogens. Cowhage and histamine induced significantly higher peak and mean itch than 
all other provocations. Temporal profile (D) as well as (E) mean and (F) peak itch intensities 
induced by 10% β-alanine when administered by 1, 5 or 25 skin punctures. No differences were 
observed. (G) Hyperknesis was present only following cowhage and histamine provocations. (H) 
Only histamine produced a robust axon-reflex-flare, while the 25 skin prick procedure caused 
(I) a small, but significant, flare reaction. NRS: numerical rating scale; SPT: skin prick test 
administration (i.e. number of punctures); VAS: visual analogue scale. Note: B, C and H as well 
as E, F and I share legends. *p < 0.05, **p < 0.01, #/##significant from all other conditions at 
p < 0.05 or p < 0.01, respectively. 
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The temporal profile of β-alanine-induced itch resembled 
a scaled down version of cowhage-evoked itch. 
β-alanine never induced significant mechanical hyper-
knesis (Fig. 1G). In contrast, cowhage and histamine 
produced mechanical hyperknesis of similar intensity (ap-
proximately 60% increases in mechanical itch sensitivity). 
Akin to cowhage, β-alanine did not produce an axon-
reflex flare, regardless of the applied concentration (Fig. 
1H), but a small homotopic erythema of 1.7 cm2 was 
recorded in the 25-punctures condition (Fig. 1I). As ex-
pected, histamine produced a pronounced neurogenic in-
flammatory response and a circumscribed wheal reaction. 
DISCUSSION
The doses of β-alanine used evoked only mild itch in 
comparison with cowhage and histamine. Furthermore, 
stimulus-response effects were non-existent, both in the 
range 2–50% and when changing the number of SPT 
punctures. β-alanine has previously been shown to induce 
mild itch and pricking on intradermal injection assessed 
by a labelled magnitude scale (8). The relative relationship 
between β-alanine and cowhage-evoked itch presently 
observed corresponds approximately to previous data 
irrespective of the psychometric scale applied (cowhage 
evoking approximately 1.5–3 times more intense itch 
than β-alanine). For intradermal injections, concentra-
tions of 50–200 mM β-alanine produced ambiguous or 
limited dose-response effects (8). Finally, rodent data 
confirm β-alanine as a weak pruritogen generally evoking 
2–4-folds less scratching than other commonly used pru-
ritogens, such as histamine and chloroquine (14).
As opposed to cowhage and histamine, β-alanine did not 
establish significant secondary mechanical hyperknesis. 
Secondary hyperknesis is thought to reflect sensitization of 
spinothalamic tract neurones transmitting itch in the spinal 
cord following robust peripheral pruriceptive barrage (2, 
13). Given the lack of robust evoked itch in the β-alanine 
conditions, it is thus not surprising that no significant hyper-
knesis was observed (13). 
A small homotopic erythematous reaction was observed 
following the administration of β-alanine using 25 skin 
punctures, probably evoked by a superficial microtrauma 
caused by repeated pinpricks. A discernible axon-reflex 
flare was observed only in the histamine condition. This 
likely reflects that only histamine effectively activates 
mechano-insensitive C-fibres, capable of producing 
a pronounced flare reaction (15), while cowhage and 
β-alanine act on mechano-heat C-fibres expressing PAR-2/ 
MrgprX1/2 (cowhage) and MrgprD (β-alanine). 
Two limitations must be kept in mind: (i) the lack of a 
dose effect could be a consequence of applying concen-
trations all at the upper plateau of the stimulus-response 
curve. However, with a 2–50% range including assessment 
of the influence of numbers of SPT punctures, this seems 
unlikely. (ii) The biochemical properties of β-alanine 
could make it ill-suited for punctate delivery and prevent 
it from reaching its substrate nerve-endings. This also 
appears unfeasible given the known superficial termina-
tion of MrgprD-expressing C-fibres (9), and the lack of 
an effect of multiple SPT punctures (16). 
While β-alanine is an easily standardizable human 
provocation model capable of evoking mild itch by both 
punctate delivery and intradermal injection, it is much less 
robust than the gold standard models utilizing histamine 
and cowhage. However, it could perhaps be applied in 
study designs where mild and brief itch is desired. Future 
studies in humans should assess other purported histamine-
independent itch mediators than β-alanine, in order to suc-
cessfully establish a reliable non-histaminergic itch model 
alternative to cowhage. 
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